GLP2-TZ (40mg)

GLP2-TZ is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Extensively studied for its potent metabolic effects, GLP2-TZ has demonstrated superior efficacy in glycemic control and weight management across clinical trial programs. It functions by enhancing insulin secretion, improving insulin sensitivity, and significantly reducing appetite through synergistic incretin receptor activation.